- Home
- GAUZ vs IKT Comparison
GAUZ vs IKT Comparison
Compare GAUZ & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAUZ
- IKT
- Stock Information
- Founded
- GAUZ 2009
- IKT 2008
- Country
- GAUZ Israel
- IKT United States
- Employees
- GAUZ N/A
- IKT N/A
- Industry
- GAUZ Industrial Machinery/Components
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- GAUZ Miscellaneous
- IKT Health Care
- Exchange
- GAUZ Nasdaq
- IKT Nasdaq
- Market Cap
- GAUZ 164.9M
- IKT 168.0M
- IPO Year
- GAUZ 2024
- IKT 2020
- Fundamental
- Price
- GAUZ $9.75
- IKT $2.00
- Analyst Decision
- GAUZ Strong Buy
- IKT Buy
- Analyst Count
- GAUZ 4
- IKT 2
- Target Price
- GAUZ $16.25
- IKT $8.00
- AVG Volume (30 Days)
- GAUZ 50.9K
- IKT 113.6K
- Earning Date
- GAUZ 05-13-2025
- IKT 05-14-2025
- Dividend Yield
- GAUZ N/A
- IKT N/A
- EPS Growth
- GAUZ N/A
- IKT N/A
- EPS
- GAUZ N/A
- IKT N/A
- Revenue
- GAUZ $103,527,000.00
- IKT N/A
- Revenue This Year
- GAUZ $32.83
- IKT N/A
- Revenue Next Year
- GAUZ $42.86
- IKT N/A
- P/E Ratio
- GAUZ N/A
- IKT N/A
- Revenue Growth
- GAUZ 32.76
- IKT N/A
- 52 Week Low
- GAUZ $6.78
- IKT $1.12
- 52 Week High
- GAUZ $17.10
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- GAUZ N/A
- IKT 46.57
- Support Level
- GAUZ N/A
- IKT $1.78
- Resistance Level
- GAUZ N/A
- IKT $2.13
- Average True Range (ATR)
- GAUZ 0.00
- IKT 0.16
- MACD
- GAUZ 0.00
- IKT -0.01
- Stochastic Oscillator
- GAUZ 0.00
- IKT 37.61
About GAUZ Gauzy Ltd. Ordinary Shares
Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.